Metsera weighs rival bids from Pfizer, Novo in $10 billion obesity drug battle – Reuters

1. Metsera weighs rival bids from Pfizer, Novo in $10 billion obesity drug battle  Reuters
2. Pfizer matches Novo bid for obesity biotech Metsera as takeover battle rages  Financial Times
3. FTC Questions Novo Nordisk’s Two-Step Acquisition of Metsera Over Antitrust Concerns  geneonline.com
4. Pfizer Responds to Delaware Chancery Court Ruling  The AI Journal
5. Metsera issues statement in response to litigation ruling  MarketScreener

Continue Reading